Just days after November’s Presidential election I outlined various ways that President-Elect Obama could use the power of the executive branch to shape U.S. marijuana policy. One of my top suggestions was:

As president, Obama can also support scientific, clinical research into the medical properties of cannabis by encouraging the DEA to abide by the February 2007 ruling of the agency’s own administrative law judge, which found that it would be “in the public interest” to allow private entities to grow medical-grade cannabis for FDA-approved trials.

Thanks to a parting shot by outgoing DEA Deputy Administrator Michele Leonhart, the new administration may never get that opportunity.

On Wednesday, January 7th, Ms. Leonhart published a 118-page decision setting aside DEA Administrative Law Judge Mary Ellen Bittner’s 2007 ruling. The DEA’s decision constitutes a formal rejection of University of Massachusetts at Amherst Professor Lyle Craker’s petition, filed initially June 24, 2001, to cultivate research-grade marijuana for use by scientists in FDA-approved studies aimed at developing the drug as a legal, prescription medication.

To those not wholly familiar with this case and Judge Bittner’s ruling, here’s how I initially reported on it:

Full Story

Like the Energizer bunny, Drug Czar John Walters’ lies just keep on coming. It was only one-month ago when the Czar made a fool of himself on cable television — denying the fact the law enforcement arrest 800,000+ individuals on pot charges each year. (The FBI’s 2008 Uniform Crime Report, released just days after Walters’ absurd denial, showed that police made a record 872,721 marijuana arrests in 2007.)

Walters further embarrassed himself by claiming that the likelihood of finding a marijuana smoker in prison or jail for pot possession is like finding a “unicorn” — a claim that is readily rebutted by the US Department of Justice’s own data, as well as by the startling number of former ‘unicorns’ who wrote to NORML here.

You’d think that these two gaffes would fulfill the Czar’s ‘lie quota’ for one day, but Walters was just getting started.  At the same press conference, Walters further alleged (read: lied) that marijuana use has fallen dramatically under his watch when, in fact, according to the government’s own data — recently crunched by George Mason University senior fellow Jon Gettman and posted to The Hill.com by MPP’s Bruce Mirken — Americans’ overall pot use rates have remained stable since 2002.

And then there’s this story, just released by ABC News.

Study: Anti-Drug Ads Haven’t Worked
Report Finds $1 Billion Campaign to Curb Teen Drug Use May Have Encouraged It
via ABC News

Despite investing $1 billion in a massive anti-drug campaign, a controversial new study suggests that the push has failed to help the United States win the war on drugs.

A congressionally mandated study released today concluded that the National Youth Anti-Drug Media Campaign launched in the late 1990s to encourage young people to stay away from drugs “is unlikely to have had favorable effects on youths.”

In fact, the study’s authors assert that anti-drug ads may have unwittingly delivered the message that other kids were doing drugs, inadvertently slowing measured progress that was being made to curb marijuana use among teenagers.

“Youths who saw the campaign ads took from them the message that their peers were using marijuana,” the report suggests as a possible reason for its findings. “In turn, those who came to believe that their peers were using marijuana were more likely to initiate use themselves.”

… “Despite extensive funding, governmental agency support, the employment of professional advertising and public relations firms, and consultation with subject-matter experts, the evidence from the evaluation suggests that the National Youth Anti-Drug Media Campaign had no favorable effects on youths’ behavior and that it may even have had an unintended and undesirable effect on drug cognitions and use,” the report said.

In other words, teens who specifically said they had a lot of exposure to the campaign messages were no less likely to stay away from marijuana than those who did not.

… The evaluation was conducted by the University of Pennsylvania’s Annenberg School for Communication, after Congress called for the study. The study was based on four rounds of interviews conducted between 1999 and 2004, each involving about 5,000 to 8,000 youths between the ages of 9 and 18 years.

Predictably, White House Office of National Drug Control Policy spokesman Tom Riley responded to the data by sticking his head in the sand. “This campaign has been a striking success,” he said — his nose growing significantly longer as he spoke.

Riley also questioned why Annenberg’s findings only assessed the White House’s public service announcements through 2004. ABC News didn’t provide an answer, so I will.

The reason Annenberg abruptly ceased evaluating the (in)effectiveness of the ONDCP’s failed media campaign in 2004 was because the National Institute on Drug Abuse — which by law was instructed to fund an independent, ongoing review of the ads — ceased paying the school’s evaluators to do so. NIDA pulled the plug on the evaluations after preliminary findings by Annenberg’s investigators found the Czar’s ad campaign to be among the least effective in the history of large-scale public communication campaigns. Somebody ought to tell John Walters, who apparently failed to get the memo.

Of course, were the mainstream media to actually do its job, Walters’ bottomless pit of documented lies and delusional fabrications would be headline news, and the reigning Czar would be looking for a new line of work (dogcatcher perhaps). Unfortunately, lying about the war on (some) drugs has become so common and pervasive among police and politicians that the fact that America’s top drug cop is completely full of, ahem, crap isn’t only acceptable, it’s actually compulsory.

So if rats can deduce that whole cannabis works better as a medicine than a single synthesized molecule, what’s stopping our federal politicians and bureaucrats from reaching this same conclusion?

Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved
via PubMed

This study aimed to give a rationale for the employment of phytocannabinoid formulations to treat neuropathic pain. It was found that a controlled cannabis extract, containing multiple cannabinoids, in a defined ratio, and other non-cannabinoid fractions (terpenes and flavonoids) provided better antinociceptive efficacy than the single cannabinoid given alone, when tested in a rat model of neuropathic pain.

On a separate but related note, am I the only one offended that most scientists appear to be more inclined to document pot’s healing powers in rats and mice than in, say, human beings?

Of course, if you want to enroll in clinical trials intent on documenting so-called “marijuana abuse,” you can take your pick here.

Study: Marijuana potency increases in 2007
via Associated Press

WASHINGTON (AP) — Marijuana potency increased last year to the highest level in more than 30 years, posing greater health risks to people who may view the drug as harmless, according to a report released Thursday by the White House.

The latest analysis from the University of Mississippi’s Potency Monitoring Project tracked the average amount of THC, the psychoactive ingredient in marijuana, in samples seized by law enforcement agencies from 1975 through 2007. It found that the average amount of THC reached 9.6 percent in 2007, compared with 8.75 percent the previous year.

The 9.6 percent level represents more than a doubling of marijuana potency since 1983, when it averaged just under 4 percent.

“Today’s report makes it more important than ever that we get past outdated, anachronistic views of marijuana,” said John Walters, director of the White House Office of National Drug Control Policy. He cited baby boomer parents who might have misguided notions that the drug contains the weaker potency levels of the 1970s.

“Marijuana potency has grown steeply over the past decade, with serious implications in particular for young people,” Walters said. He cited the risk of psychological, cognitive and respiratory problems, and the potential for users to become dependent on drugs such as cocaine and heroin.

While the drug’s potency may be rising, marijuana users generally adjust to the level of potency and smoke it accordingly, said Dr. Mitch Earleywine, who teaches psychology at the State University of New York in Albany and serves as an adviser for marijuana advocacy groups. “Stronger cannabis leads to less inhaled smoke,” he said.

The White House office attributed the increases in marijuana potency to sophisticated growing techniques that drug traffickers are using at sites in the United States and Canada.

…

“The increases in marijuana potency are of concern since they increase the likelihood of acute toxicity, including mental impairment,” said Dr. Nora Volkow, director of the National Institute on Drug Abuse, which funded the University of Mississippi study.

When I was in journalism school, the rule of thumb was that you needed to have your facts confirmed by three separate sources before a news story was ‘fit to print.’ By that standard, the ‘three sources’ cited in the story above — White House Drug Czar (and chronic liar) John Walters, NIDA’s (US National Institute on Drug Abuse) Potency Monitoring Project, and Nora Volkow, who heads the rabidly anti-drug propaganda agency that paid for the Monitoring Project study — don’t even add up to one.

Fortunately, the AP did at least demonstrate the good sense to speak with SUNY Albany Professor (and NORML Advisory Board member) Mitch Earleywine, who stated the obvious factoid overlooked by the White House: As the potency of pot rises, people simply smoke less of it. Mitch could have also noted that most cannabis consumers actually prefer less potent pot, just as the majority of those who drink alcohol prefer beer or wine over hard liquor. Or he could have mentioned how doctors may legally prescribe a FDA-approved non-toxic pill that contains 100 percent THC, and curiously, nobody at NIDA or at the Drug Czar’s office seems particularly concerned about it. Strangely, AP writer Hope Yen felt the need to identify Dr. Earleywine, who has authored numerous peer-reviewed studies and books on various aspects of cannabis, as “an adviser for marijuana advocacy groups,” but felt no such need to identify Mr. Walters or Ms. Volkow as “those who favor arresting and jailing adults who use marijuana, even when their use is for medical purposes.”

Of course, in an effort to get to the bottom of the so-called “potent pot” story, Ms. Yen might have thought to inquire why the US National Drug Intelligence Center’s 2007 National Drug Threat Assessment states, “Most of the marijuana available in the domestic drug markets is lower potency commercial-grade marijuana.” Geez, you’d think that the various prohibitionist branches of the US government would at least get their stories straight!

Oh well, since lying about the alleged dangers of allegedly more potent pot is now an annual tradition (Remember “Pot 2.0” anybody?), there’s always next year.

A funny thing happens when the US government begrudgingly allows for double-blind, placebo-controlled clinical trials evaluating the therapeutic efficacy of inhaled cannabis.  

Investigators discover time after time that it works! 

Here are the results from the latest study, conducted at California’s Center for Medical Cannabis Research.   

Low-dose pot eases pain while keeping mind clear
via Reuters News Wire

NEW YORK (Reuters Health) — Giving carefully calibrated doses of smoked marijuana to people with neuropathic pain, which can be difficult-to-treat and extremely painful, can ease their pain without clouding their minds, California researchers report.

Read the full story here. 

Unfortunately, according to recently released legal filings, fewer than 20 investigators in the United States currently possess federal approval to conduct legal clinical research on whole smoked cannabis. (Not surprisingly, most of these researchers are conducting trials that seek to assess the potential physical and mental harms allegedly associated with the drug.) In addition, state funding for the CMCR — which has backed virtually all of the medical cannabis research conducted over the past several years — has dried up and no new appropriations are likely.

Of course, federal officials could readily step in with grant money to keep this important clinical research going — after all, just last month the US National Institute on Drug Abuse announced that it would be spending millions to establish the first-ever ‘Center on Cannabis Addiction‘ — but, needless to say, I’m not holding my breath.

According to a recent UPI news wire story, researchers are now proposing prescribing the psychoactive prescription drug Lithium to so-called ‘pot addicts’ to help them kick the habit.  But just who are these alleged ‘addicts?’    

According to the latest statistics from the US Department of Health and Human Services, a startling high number of US government-defined marijuana ‘addicts’ don’t even smoke pot! That’s right, according to a recent DHS report, more than one-third of Americans entered into drug treatment with a primary diagnosis of marijuana ‘dependency’ haven’t used pot in the month prior to their admission.

How’s this possible? It’s possible because the majority of folks admitted to ‘drug treatment’ for pot don’t need treatment at all, but were arrested and ordered by a judge to attend rehab in lieu of going to jail.

Nevertheless, the White House touts this phony ‘data’ as evidence that marijuana is allegedly more dangerous than cocaine or heroin, and NIDA touts these numbers as evidence to support multi-million dollar ‘Cannabis Addiction Centers.’

Looking for the truth about marijuana use and dependency? Look no further than my recent Alternet.org essay on the subject here, or you can ‘digg’ it here.